维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Panetta JC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics,but not severe toxicity in patients receiving low-dose irinotecan显示文摘	Stewart CF Panetta JC O’Shaughnessy MA	2007	J Clin Oncol2007，25，18：	1
2	Population pharmacoki- netic studies in pediatrics: issues in design and analysis 显示文摘	Meibohm B Laer S Panetta JC	2005	AAPS J2005，7，2：	1
3	Plasma and cere- brespinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-42(}显示文摘	Broniscer A Panetta JC O'Shaughnessy M	2007	Cfin Cancer Res2007，13，5：	1
4	Population pharmacokinetic analysis of topotecan in pediatric cancer patients 显示文摘	Schaiquevich P Panetta JC Iacono LC	2007	Clin Cancer Res2007，13，：	1
5	Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia显示文摘	Panetta JC Wilkinson M Pui CH	2002	J Pharmacokinet Pharmacodyn2002，29，2：	1
6	Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia显示文摘	Hijiya N Panetta JC Zhou Y	2006	Blood2006，108，：	1
7	Methotrexate intracellular disposition in acute lymphoblastic leukemia:a mathematical model of gamma-glutamyl hydrolase activity显示文摘	Panetta JC Wall A Pui CH	2002	Clin Cancer Res2002，8，7：	1
8	UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan显示文摘	Stewart CF Panetta JC O'Shaughnessy MA	2007	J Clin Oncol2007，25，18：	1
9	Population pharmacokinetic studies in pediatrics: issues in design and analysis显示文摘	Meibohm B Laer S Panetta JC	2005	AAPS J2005，7，2：	1
10	UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics,but not severe toxicity in patients receiving low-dose irinotecan显示文摘	Stewart CF Panetta JC O'Shaughnessy MA	2007	J Clin Oncol2007，25，18：	1
11	Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia显示文摘	Yang L Panetta JC Cai X	2008	J Clin Oncol2008，26，12：	1
12	Limited and optimal sampling strategies for etop oside and etoposide catechol in children with leukemia显示文摘	Panetta JC Wilkinson M Pui CH	2002	J Pharmacokinet Pharmacodyn2002，29，：	1
13	Genome-wide study of methotre- xate clearance replicates SLCO1 B1 显示文摘	Rarnsey LB Panetta JC Smith C	2013	Blood2013，121，6：	1
14	Plasma and cerebrospinal fluid pharmacokinetics of erlotinib its active metabolite (OSI-420)显示文摘	Broniscer A Panetta JC Fraga C	2007	Clin Cancer Res2007，13，5：	1
15	Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo 显示文摘	Leggas M Panetta JC Zhuang Y	2006	Cancer Res2006，66，：	1
16	Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 显示文摘	Broniscer A Panetta JC O'Shaughnessy M	2007	Clin Cancer Res2007，13，5：	1
17	fluid pharmacokinetics of erlotinib and its active metabolite osi-420显示文摘	Broniscer A Panetta JC Plasma and cerebrospinal O'Shaughnessy M	2007	Clin Cancer Res2007，13，5：	1
18	Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia显示文摘	Yang L Panetta JC Cai X	2008	JClinOncol2008，26，12：	1
19	Populationpharmacokinetics of temozolomide and metabolites in infants andchildren with primary central nervous system tumors显示文摘	PANETTA JC KIRSTEIN MN GAJJAR A	2003	CancerChemother Pharm2003，52，6：	1
20	Modeling immunotherapy of the tumor-immune interaction显示文摘	Kirschner D Panetta JC	1998	J Math Biol1998，37，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示